ROKIT HEALTHCARE Inc. Logo

ROKIT HEALTHCARE Inc.

Uses 3D bioprinting and AI for autologous organ regeneration to treat chronic conditions.

376900 | KO

Overview

Corporate Details

ISIN(s):
KR7376900007
LEI:
Country:
South Korea
Address:
서울특별시 금천구 디지털로10길 9, 12층, 서울특별시
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

ROKIT HEALTHCARE Inc. is a biotechnology company specializing in hyper-personalized organ regeneration and regenerative medicine. Established in 2012, the company develops and commercializes advanced healthcare solutions centered on its proprietary 3D and 4D bioprinting technologies, specialized bioinks, and AI-driven platforms. Its primary focus is on providing effective treatments for chronic conditions, such as diabetic foot ulcers and skin ailments, by shifting the treatment paradigm from conventional surgery to autologous organ regeneration. The company has secured patents for its innovative multi-organ bioprinting technology, aiming to offer safer and more effective therapeutic options worldwide.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-12 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 48.9 KB
2025-09-11 00:00
Pre-Annual General Meeting Information
주주총회소집결의 (임시주주총회)
Korean 6.8 KB
2025-09-11 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정 (임시주주총회)
Korean 4.3 KB
2025-08-14 00:00
Interim / Quarterly Report
반기보고서 (2025.06)
Korean 1.6 MB
2025-08-01 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.3 KB
2025-07-18 00:00
Share Issue/Capital Change
증권발행결과(자율공시)
Korean 5.6 KB
2025-07-16 00:00
Capital/Financing Update
주요사항보고서(전환사채권발행결정)
Korean 72.0 KB
2025-05-19 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 118.9 KB
2025-05-19 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-05-19 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.9 KB
2025-05-19 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.9 KB
2025-05-19 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.9 KB
2025-05-19 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.9 KB
2025-05-19 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.9 KB
2025-05-19 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.9 KB

Automate Your Workflow. Get a real-time feed of all ROKIT HEALTHCARE Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ROKIT HEALTHCARE Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ROKIT HEALTHCARE Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Sds Optic Spolka Akcyjna Logo
Develops fiber-optic diagnostic tech for real-time, in-vivo cancer biomarker analysis.
Poland
SDS
Seer, Inc. Logo
Provides researchers a platform for deep, unbiased, large-scale access to the proteome.
United States of America
SEER
Selvita S.A. Logo
Preclinical CRO offering integrated drug discovery and development services for life sciences.
Poland
SLV
SensoDetect AB Logo
AI tool providing objective ADHD & autism diagnosis via brain response to sound.
Sweden
SDET
Sensorion Logo
Developing gene therapies and small molecules to restore, treat, and prevent hearing loss.
France
ALSEN
Senti Biosciences, Inc. Logo
Developing smart cell and gene therapies with Gene Circuits to precisely target cancer.
United States of America
SNTI
SeouLinBioscienceCO.,LTD. Logo
South Korea
038070
Septerna, Inc. Logo
Advancing novel small molecule GPCR medicines for endocrine, immune, and metabolic diseases.
United States of America
SEPN
SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. Logo
A contract research organization providing preclinical and clinical services for medical industries.
Japan
2395
Silence Therapeutics plc Logo
Develops RNAi therapies that silence disease genes for rare and underserved conditions.
United States of America
SLN

Talk to a Data Expert

Have a question? We'll get back to you promptly.